Championship Sunday has arrived at the 126th U.S. Open, and Wyndham Clark stands on the verge of capturing his second U.S. Open title in four years. MORE: 5 most complete major championship golfers of ...

The cut has been made at the 2026 U.S. Open at Shinnecock Hills, and the third round awaits those players who survived to play on. If you’re wondering what channel the U.S. Open is on Saturday, we ...

The 126th U.S. Open rolls into the weekend at Shinnecock Hills Golf Club. Wyndham Clark, the 2023 champion, holds a four-shot lead over Matt Fitzpatrick, Sam Stevens, Xander Schauffele and Tom Kim.

SOUTHAMPTON, N.Y. -- The U.S. Open is off and rolling. After a blistering Round 1 that saw gusty winds batter players early before laying down a bit in the afternoon, the players are back for more on ...

Thanks to a two-hour fog suspension on Thursday, Round 1 of the 126th U.S. Open concluded Friday morning. Play resumed at 6:35 a.m. ET with Round 2 tee times pushed back 15 minutes from their original ...

SOUTHAMPTON, N.Y. -- The 2026 U.S. Open has arrived with 72 holes of pristine golf remaining at a regular but relatively rare stop on USGA's major rotation, Shinnecock Hills. The action begins ...

The third major of the PGA Tour golf season has arrived. The world's best golfers head to Long Island as it's time for the 2026 U.S. Open at Shinnecock Hills Golf Club in New York. One of the major ...

For one more warmup before the U.S. Open, the PGA Tour heads north of the border for the RBC Canadian Open. And while world No. 1 Scottie Scheffler and No. 2 Rory McIlroy won't be there at TPC Toronto ...

"Golf's Longest Day" is the official beginning of the U.S. Open, as players seek to earn the last few spots in the third major of the year later this month. While this year's U.S. Open returns to ...

Paramount Skydance Corp. is prepared — if necessary — to divest some children’s TV network assets to help win European Union approval of its $110 billion bid for Warner Bros. Discovery Inc. While ...

This year’s meeting of the American Society of Clinical Oncology is abuzz with talk of RAS inhibitors, largely driven by Revolution Medicines’ barnburner pancreatic cancer data drop earlier this year.